Ocular Hypertension
Showing NaN - NaN of 28
Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)
Recruiting
- Ocular Hypertension
- Latanoprostene Bunod
- Placebo
-
Rochester, MinnesotaBausch Site 001
Sep 29, 2022
Ocular Hypertension Trial in Rochester (Scleral Lens)
Recruiting
- Ocular Hypertension
- Scleral Lens
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 1, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Brimonidine Tartrate Ophthalmic Suspension
- Brimonidine Tartrate Ophthalmic Solution
-
Chandler, Arizona
- +46 more
Jan 27, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate
Completed
- Primary Open Angle Glaucoma
- Ocular Hypertension
- DE-126 Ophthalmic Solution 0.002% QD
- Timolol Maleate Ophthalmic Solution 0.5% BID
-
Chandler, Arizona
- +40 more
Feb 10, 2022
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost
- Placebo Vehicle
-
Artesia, California
- +9 more
Sep 14, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Xalacom
- +2 more
-
Birmingham, Alabama
- +63 more
Feb 17, 2021
Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)
Completed
- Ocular Hypertension
- Primary Open Angle Glaucoma
- Latanoprost ophthalmic solution
- +2 more
-
Inglewood, California
- +20 more
Jan 13, 2021
Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)
Completed
- Glaucoma
- Ocular Hypertension
-
Artesia, California
- +28 more
Dec 11, 2020
Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost
Completed
- Primary Open Angle Glaucoma
- +3 more
- PF-03187207 and Latanoprost Vehicle
- Latanoprost 0.005% and PF-03187207 Vehicle
-
Artesia, California
- +18 more
Sep 10, 2020
Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Phoenix, Arizona
- +105 more
May 29, 2020
Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- bimatoprost 20 µg generation 2
- +6 more
-
Artesia, California
- +56 more
Mar 27, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Phentolamine Mesylate Ophthalmic Solution 1%
- Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
-
Mission Hills, California
- +4 more
Oct 10, 2019
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG324 Ophthalmic Solution 0.01%
- +3 more
-
Artesia, California
- +22 more
May 14, 2019
Open-Angle Glaucoma, Ocular Hypertension Trial in Rochester (BOL-303259-X, Timolol)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
-
Rochester, New YorkBausch & Lomb Inc.
Oct 25, 2018
Open-Angle Glaucoma, Ocular Hypertension Trial in Rochester (BOL-303259-X, Timolol)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
-
Rochester, New YorkBausch & Lomb Inc.
Oct 10, 2018
Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose
Completed
- Open-angle Glaucoma
- Ocular Hypertension
- DE-117 Low Dose ophthalmic solution
- +5 more
-
Chandler, Arizona
- +13 more
Apr 16, 2018
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +3 more
-
Newport Beach, California
- +10 more
Mar 19, 2018
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +2 more
-
Artesia, California
- +21 more
Mar 19, 2018
Glaucoma, Ocular Hypertension Trial in United States (0.25% AR-12286 / 0.004% travoprost, 0.5% AR-12286, 0.004% travoprost,
Completed
- Glaucoma
- Ocular Hypertension
- 0.25% AR-12286 / 0.004% travoprost
- +2 more
-
Inglewood, California
- +8 more
Sep 12, 2016
Glaucoma, Ocular Hypertension Trial in United States (Latanoprost 0.005%, AR-12286 Ophthalmic Solution 0.5%, Timolol maleate
Completed
- Glaucoma
- Ocular Hypertension
- Latanoprost 0.005%
- +2 more
-
New Haven, Connecticut
- +14 more
Apr 18, 2014
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG286 Ophthalmic Solution 0.5%
- +2 more
-
Artesia, California
- +20 more
Feb 17, 2014
Glaucoma, Open-Angle, Ocular Hypertension Trial in Rochester (AGN-210669 ophthalmic solution, 0.1%, AGN-210669 ophthalmic
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- AGN-210669 ophthalmic solution, 0.1%
- +3 more
-
Rochester, New York(unnamed)
Aug 13, 2013
Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- No Treatment
-
Rochester, New York(unnamed)
Jul 16, 2013